Global Atrial Fibrillation Devices Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

This report studies the Atrial Fibrillation Devices market. Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Atrial Fibrillation Devices are the devices used for atrial fibrillation therapy, including access, diagnostic, visualization and ablation products to assist physicians in diagnosing and treating various irregular heart rhythms.

Scope of the Report:
About 4.4% people out of diagnosed atrial fibrillation population are treated using ablation technology in the U.S., Europe, and Japan combined. The atrial fibrillation population treated with ablation is expected to grow with a double digit rate in these regions. The increasing prevalence of atrial fibrillation and advancement in the ablation technologies drive the use of ablation products in the treatment of atrial fibrillation.
This market is segmented, on the basis of surgical procedures, into catheter ablation and surgical ablation. Catheter ablation procedures hold the maximum share in this market and are expected to grow with the highest CAGR during forecast period of 2018 to 2025.
The geographical segmentation includes North America, Europe, Asia-Pacific, South America and Middle East & Africa. North America holds the largest share in this market. However, Asia-Pacific is expected to witness the highest growth rate owing to the presence of a large patient population, growing medical tourism, and high focus of global market players on emerging Asia-Pacific countries such as China and India.
The worldwide market for Atrial Fibrillation Devices is expected to grow at a CAGR of roughly 9.3% over the next five years, will reach 4100 million US$ in 2024, from 2410 million US$ in 2019, according to a new study.
This report focuses on the Atrial Fibrillation Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
St. Jude Medical
Boston Scientific
Biosense Webster
Medtronic
Japan Lifeline
AtriCure
Biotronik
Philips
Synaptic Medical
Osypka AG
MicroPort Scientific
CardioFocus
Lepu Medical
APT Med
TZ Medical

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Catheter Ablation
Maze Surgery

Market Segment by Applications, can be divided into
Hospitals
Clinics
Ambulatory Surgical Centers
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Atrial Fibrillation Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Atrial Fibrillation Devices, with price, sales, revenue and global market share of Atrial Fibrillation Devices in 2017 and 2018.
Chapter 3, the Atrial Fibrillation Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Atrial Fibrillation Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Atrial Fibrillation Devices market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Atrial Fibrillation Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.